CJC-1295 + Ipamorelin Blend is a dual-peptide research combination consisting of two structurally defined synthetic peptide sequences supplied together in a single vial. This blend is referenced in preclinical research contexts where combined peptide models are investigated under controlled laboratory conditions.
| Compound Name | CJC-1295 + Ipamorelin Blend 20mg |
| Structure | Dual Synthetic Peptide Blend |
| Purity | ≥99% (HPLC Verified) — each component |
| Property | Value |
|---|---|
| Compound Name | CJC-1295 + Ipamorelin Blend 20mg |
| Synonyms | CJC-1295 (No DAC) + Ipamorelin Research Combination |
| Structure Type | Dual Synthetic Peptide Blend |
| Purity | ≥99% (HPLC Verified) — each component |
| Form | Lyophilized Powder Blend |
| Quantity | 20 mg per vial (10 mg + 10 mg) |
| Storage | -20°C, desiccated, protect from light |
| Shelf Life | 24 months |
| Country of Origin | United States |
| Intended Use | Research purposes only |
| Attribute | Details |
|---|---|
| SKU | CBL-CJCIPA-20 |
| Category | Blends |
| Documentation | Batch-specific COA available on request |
| Testing Method | HPLC with UV detection; MS confirmation available |
| Regulatory Status | Research Use Only. Not for human or veterinary administration. |
Your cart is empty
